跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 117 条关于
“CX3CR1”
全部
117
临床试验
59
药物
45
机构
0
资讯
13
2个月前
Novakand Pharma Pivots to Orphan Drug Development for Treatment-Resistant Ovarian Cancer and Leukemia
去年
Baseline Steroid Use Significantly Reduces Immune Checkpoint Inhibitor Effectiveness in NSCLC Patients
去年
Rheumatoid Arthritis: Macrophage Subtype Identified as Potential Target for Early Diagnosis and Treatment
去年
Researchers Identify Key Resistance Mechanism to CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
3个月前
MAaGI Medical's "i" Series Multimodal Tumor Therapy Debuts at APSCVIR 2026, Showcasing 8-Month OS Improvement in Pancreatic Cancer
去年
Exicure Secures Australian Patent for Novel Cancer Treatment Targeting CXCR4 and GPCRx
6个月前
Pentixapharm Receives FDA Approval for CXCR4-Targeted Radiotheranostic Program in Blood Cancers
去年
Pentixapharm Pivots Clinical Strategy to Focus on CXCR4-Targeted Theranostic Oncology Platform
11个月前
Pentixapharm's CXCR4-Targeted Radiopharmaceuticals Show Promise in Primary Aldosteronism and Bladder Cancer
去年
Anti-CXCR4 and Anti-PD-1 Combination Shows Promise in Liver Cancer Treatment
第 1 页,共 2 页
上一页
下一页